[
    {
        "question_id": "1_B_250",
        "new_question_id": "9556",
        "question_type": "0",
        "category": "8",
        "concept_id_link": "785",
        "notes_id_link": "1_621",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Doxorubicin",
            "Cyclophosphamide",
            "Methotrexate",
            "Vincristine",
            "Bleomycin",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 48-year-old female who has just completed a course of chemotherapy complains of difficulty using her hands associated with 'pins and needles'. She has also experienced urinary hesitancy. Which cytotoxic drug is most likely to be responsible?",
            "",
            ""
        ],
        "answers": [
            "4",
            "",
            ""
        ],
        "notes": [
            "Vincristine is associated with peripheral neuropathy. Urinary hesitancy may develop secondary to bladder atony.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 48-year-old female who has just completed a course of chemotherapy complains of difficulty using her hands associated with 'pins and needles'. She has also experienced urinary hesitancy. Which cytotoxic drug is most likely to be responsible?",
        "correct_answer": "4",
        "question_notes": "Vincristine is associated with peripheral neuropathy. Urinary hesitancy may develop secondary to bladder atony.",
        "answer_order": "4",
        "answer": "4",
        "title": "Cytotoxic agents",
        "body": "The tables below summarises the mechanism of action and major adverse effects of commonly used cytotoxic agents.<br /><br /><h5 class='notes-heading'>Alkylating agents</h5><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b>Cytotoxic</b></th><th><b>Mechanism of action</b></th><th><b>Adverse effects</b></th></tr></thead><tbody><tr><td>Cyclophosphamide</td><td><span class=\"concept\" data-cid=\"6235\">Alkylating agent - causes cross-linking in DNA</span></td><td><span class=\"concept\" data-cid=\"6225\">Haemorrhagic cystitis</span>, <span class=\"concept\" data-cid=\"6226\">myelosuppression</span>, <span class=\"concept\" data-cid=\"2707\">transitional cell carcinoma</span></td></tr></tbody></table></div><br /><h5 class='notes-heading'>Cytotoxic antibiotics</h5><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid2\" ><thead><tr><th><b>Cytotoxic</b></th><th><b>Mechanism of action</b></th><th><b>Adverse effects</b></th></tr></thead><tbody><tr><td>Bleomycin</td><td><span class=\"concept\" data-cid=\"6232\">Degrades preformed DNA</span></td><td><span class=\"concept\" data-cid=\"6220\">Lung fibrosis</span></td></tr><tr><td>Anthracyclines (e.g doxorubicin)</td><td><span class=\"concept\" data-cid=\"6233\">Stabilizes DNA-topoisomerase II complex   inhibits DNA & RNA synthesis</span></td><td><span class=\"concept\" data-cid=\"6221\">Cardiomyopathy</span></td></tr></tbody></table></div><br /><h5 class='notes-heading'>Antimetabolites</h5><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid3\" ><thead><tr><th><b>Cytotoxic</b></th><th><b>Mechanism of action</b></th><th><b>Adverse effects</b></th></tr></thead><tbody><tr><td>Methotrexate</td><td><span class=\"concept\" data-cid=\"6234\">Inhibits dihydrofolate reductase and thymidylate synthesis</span></td><td><span class=\"concept\" data-cid=\"6222\">Myelosuppression</span>, <span class=\"concept\" data-cid=\"6223\">mucositis</span>, <span class=\"concept\" data-cid=\"6224\">liver fibrosis</span>, <span class=\"concept\" data-cid=\"4323\">lung fibrosis</span></td></tr><tr><td>Fluorouracil (5-FU)</td><td><span class=\"concept\" data-cid=\"6237\">Pyrimidine analogue inducing cell cycle arrest and apoptosis by blocking thymidylate synthase (works during S phase)</span></td><td><span class=\"concept\" data-cid=\"6227\">Myelosuppression</span>, <span class=\"concept\" data-cid=\"6228\">mucositis</span>, <span class=\"concept\" data-cid=\"6229\">dermatitis</span></td></tr><tr><td>6-mercaptopurine</td><td><span class=\"concept\" data-cid=\"6242\">Purine analogue that is activated by HGPRTase, decreasing purine synthesis</span></td><td>Myelosuppression</td></tr><tr><td>Cytarabine</td><td><span class=\"concept\" data-cid=\"6245\">Pyrimidine antagonist. Interferes with DNA synthesis specifically at the S-phase of the cell cycle and inhibits DNA polymerase</span></td><td><span class=\"concept\" data-cid=\"6246\">Myelosuppression</span>, <span class=\"concept\" data-cid=\"6247\">ataxia</span></td></tr></tbody></table></div><br /><h5 class='notes-heading'>Acts on microtubules</h5><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid4\" ><thead><tr><th><b>Cytotoxic</b></th><th><b>Mechanism of action</b></th><th><b>Adverse effects</b></th></tr></thead><tbody><tr><td>Vincristine, vinblastine</td><td><span class=\"concept\" data-cid=\"6230\">Inhibits formation of microtubules</span></td><td>Vincristine: <span class=\"concept\" data-cid=\"785\">Peripheral neuropathy (reversible)</span> , <span class=\"concept\" data-cid=\"6239\">paralytic ileus</span><br />Vinblastine: <span class=\"concept\" data-cid=\"6240\">myelosuppression</span></td></tr><tr><td>Docetaxel</td><td><span class=\"concept\" data-cid=\"787\">Prevents microtubule depolymerisation & disassembly, decreasing free tubulin</span></td><td>Neutropaenia</td></tr></tbody></table></div><br /><h5 class='notes-heading'>Topoisomerase Inhibitors</h5><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid5\" ><thead><tr><th><b>Cytotoxic</b></th><th><b>Mechanism of action</b></th><th><b>Adverse effects</b></th></tr></thead><tbody><tr><td>Irinotecan</td><td><span class=\"concept\" data-cid=\"9280\">Inhibits topoisomerase I which prevents relaxation of supercoiled DNA</span></td><td>Myelosuppression</td></tr></tbody></table></div><br /><h5 class='notes-heading'>Other cytotoxic drugs</h5><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid6\" ><thead><tr><th><b>Cytotoxic</b></th><th><b>Mechanism of action</b></th><th><b>Adverse effects</b></th></tr></thead><tbody><tr><td>Cisplatin</td><td><span class=\"concept\" data-cid=\"6231\">Causes cross-linking in DNA</span></td><td><span class=\"concept\" data-cid=\"12272\">Nephrotoxicity (the primary dose-limiting side effect)</span>, <span class=\"concept\" data-cid=\"6219\">Ototoxicity</span>, <span class=\"concept\" data-cid=\"788\">peripheral neuropathy</span>, <span class=\"concept\" data-cid=\"786\">hypomagnesaemia</span></td></tr><tr><td>Hydroxyurea (hydroxycarbamide)</td><td><span class=\"concept\" data-cid=\"6243\">Inhibits ribonucleotide reductase, decreasing DNA synthesis</span></td><td><span class=\"concept\" data-cid=\"6244\">Myelosuppression</span></td></tr></tbody></table></div>",
        "notes_hash": "8b3d85754acea1f462557a8a6ac97eb4",
        "knowledge_graph_node_id_link": 0,
        "concept": "Vincristine - peripheral neuropathy",
        "concept_percentile": "28",
        "concept_colour": "rgb(255,142,0)",
        "number_attempts": "5426",
        "up_votes": "40",
        "down_votes": "30",
        "column_array": [
            0,
            "375",
            "1157",
            "417",
            "3150",
            "327",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Toxicity Bear's very own website</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1494\" data-linkid=\"1494\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1494\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">417</span><button type=\"button\" style=\"\" id=\"link_dislike_1494\" data-linkid=\"1494\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1494\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">18</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://pbs.twimg.com/media/BKVx5a3CUAAa1z2.png\">Toxicity Bear</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/t7QDJOXeux4\" data-description=\"Pharmacology - Chemotherapy agents\" data-upvotes=\"13\" data-downvotes=\"2\" data-media=\"834\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/t7QDJOXeux4/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/t7QDJOXeux4\" data-description=\"Pharmacology - Chemotherapy agents\" data-upvotes=\"13\" data-downvotes=\"2\" data-media=\"834\">Pharmacology - Chemotherapy agents</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1461\" data-mediaid=\"1461\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1461\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">13</span><button type=\"button\" style=\"\" id=\"media_dislike_1461\" data-mediaid=\"1461\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1461\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/VD8h0XsEFho\" data-description=\"Cancer Pharmacology\" data-upvotes=\"6\" data-downvotes=\"3\" data-media=\"1025\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/VD8h0XsEFho/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/VD8h0XsEFho\" data-description=\"Cancer Pharmacology\" data-upvotes=\"6\" data-downvotes=\"3\" data-media=\"1025\">Cancer Pharmacology</a></td></tr><tr><td><span ><small>DirtyUSMLE - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1802\" data-mediaid=\"1802\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1802\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">6</span><button type=\"button\" style=\"\" id=\"media_dislike_1802\" data-mediaid=\"1802\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1802\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/gYIAFXlfEw8\" data-description=\"Microtubule inhibitors\" data-upvotes=\"1\" data-downvotes=\"1\" data-media=\"1359\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/gYIAFXlfEw8/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/gYIAFXlfEw8\" data-description=\"Microtubule inhibitors\" data-upvotes=\"1\" data-downvotes=\"1\" data-media=\"1359\">Microtubule inhibitors</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2389\" data-mediaid=\"2389\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2389\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1</span><button type=\"button\" style=\"\" id=\"media_dislike_2389\" data-mediaid=\"2389\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2389\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr></table>",
        "comment_count": 9,
        "concepts_for_notes": {
            "785": {
                "concept_text": "Vincristine - peripheral neuropathy",
                "concept_percentile": "28"
            },
            "786": {
                "concept_text": "Cisplatin is associated with hypomagnesaemia",
                "concept_percentile": "1"
            },
            "6219": {
                "concept_text": "Cisplatin may cause ototoxicity",
                "concept_percentile": "10"
            },
            "6220": {
                "concept_text": "Bleomycin may cause pulmonary fibrosis",
                "concept_percentile": "20"
            },
            "6221": {
                "concept_text": "Anthracyclines (e.g. doxorubicin) may cause cardiomyopathy",
                "concept_percentile": "15"
            },
            "6222": {
                "concept_text": "Methotrexate may cause myelosuppression/agranulocytosis",
                "concept_percentile": "100"
            },
            "6223": {
                "concept_text": "Methotrexate may cause mucositis",
                "concept_percentile": "99"
            },
            "6224": {
                "concept_text": "Methotrexate may cause liver fibrosis",
                "concept_percentile": "100"
            },
            "6225": {
                "concept_text": "Cyclophosphamide may cause haemorrhagic cystitis",
                "concept_percentile": "4"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_1754",
        "new_question_id": "11192",
        "question_type": "0",
        "category": "2",
        "concept_id_link": "0",
        "notes_id_link": "1_973",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Topical clindamycin",
            "Topical azelaic acid",
            "Topical benzoyl peroxide",
            "Topical erythromycin",
            "Topical isotretinoin",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 20-year-old woman who is in the second trimester of her first pregnancy comes for review. Unfortunately her longstanding acne has flared again and she is keen to try something to improve the situation. Which one of the following should be avoided?",
            "",
            ""
        ],
        "answers": [
            "5",
            "",
            ""
        ],
        "notes": [
            "Topical isotretinoin is a type of retinoid and is therefore strongly contraindicated in pregnancy, even in the topical form.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 20-year-old woman who is in the second trimester of her first pregnancy comes for review. Unfortunately her longstanding acne has flared again and she is keen to try something to improve the situation. Which one of the following should be avoided?",
        "correct_answer": "5",
        "question_notes": "Topical isotretinoin is a type of retinoid and is therefore strongly contraindicated in pregnancy, even in the topical form.",
        "answer_order": "5",
        "answer": "5",
        "title": "Acne vulgaris: management",
        "body": "Acne vulgaris is a common skin disorder which usually occurs in adolescence. It typically affects the face, neck and upper trunk and is characterised by the obstruction of the pilosebaceous follicles with keratin plugs which results in comedones, inflammation and pustules.<br /><br />Acne may be classified into mild, moderate or severe:<br /><ul><li>mild: open and closed comedones with or without sparse inflammatory lesions</li><li>moderate acne: widespread non-inflammatory lesions and numerous papules and pustules</li><li>severe acne: extensive inflammatory lesions, which may include nodules, pitting, and scarring</li></ul><br />For people with mild to moderate acne: #link42 <br /><ul><li>a 12-week course of <span class=\"concept\" data-cid=\"2616\">topical combination therapy should be tried first-line</span>:<ul><li>a fixed combination of topical adapalene with topical benzoyl peroxide</li><li>a fixed combination of topical tretinoin with topical clindamycin</li><li>a fixed combination of topical benzoyl peroxide with topical clindamycin</li></ul></li><li>topical benzoyl peroxide may be used as monotherapy if these options are contraindicated or the person wishes to avoid using a topical retinoid or an antibiotic</li></ul><br />For people with <span class=\"concept\" data-cid=\"1117\">moderate to severe acne</span>: #link41 <br /><ul><li>a 12-week course of one of the following options:<ul><li>a fixed combination of topical adapalene with topical benzoyl peroxide </li><li>a fixed combination of topical tretinoin with topical clindamycin </li><li>a fixed combination of topical adapalene with topical benzoyl peroxide + either oral lymecycline or oral doxycycline</li><li>a topical azelaic acid + either oral lymecycline or oral doxycycline</li></ul></li><li>important points about oral antibiotic usage:<ul><li><span class=\"concept\" data-cid=\"1119\">tetracyclines should be avoided in pregnant or breastfeeding women and in children younger than 12 years of age</span>. <span class=\"concept\" data-cid=\"957\">Erythromycin may be used in pregnancy</span></li><li>minocycline is now considered less appropriate due to the possibility of irreversible pigmentation</li><li><span class=\"concept\" data-cid=\"9811\">only continue a treatment option that includes an antibiotic (topical or oral) for more than 6 months in exceptional circumstances</span></li><li>a topical retinoid (if not contraindicated) or benzoyl peroxide should always be co-prescribed with oral antibiotics to reduce the risk of antibiotic resistance developing. <span class=\"concept\" data-cid=\"10230\">Topical and oral antibiotics should not be used in combination</span></li><li>Gram-negative folliculitis may occur as a complication of long-term antibiotic use - high-dose oral trimethoprim is effective if this occurs</li></ul></li><li><span class=\"concept\" data-cid=\"2620\">combined oral contraceptives (COCP) are an alternative to oral antibiotics in women</span><ul><li>as with antibiotics, they should be used in combination with topical agents</li><li><span class=\"concept\" data-cid=\"2621\">Dianette (co-cyprindiol) is sometimes used as it has anti-androgen properties. However, it has an increased risk of venous thromboembolism compared to other COCPs, therefore it should generally be used second-line, only be given for 3 months and women should be appropriately counselled about the risks</span></li></ul></li><li>oral isotretinoin: <span class=\"concept\" data-cid=\"2622\">only under specialist supervision</span><ul><li><span class=\"concept\" data-cid=\"10229\">pregnancy is a contraindication to topical and oral retinoid treatment</span></li></ul></li></ul><br />To reduce the risk of antibiotic resistance developing the following should not be used to treat acne:  #link40 <br /><ul><li><span class=\"concept\" data-cid=\"12096\">monotherapy with a topical antibiotic</span></li><li><span class=\"concept\" data-cid=\"12096\">monotherapy with an oral antibiotic</span></li><li><span class=\"concept\" data-cid=\"10230\">a combination of a topical antibiotic and an oral antibiotic</span></li></ul><br />NICE referral criteria #link39 <br /><ul><li>the following patients should be referred to a dermatologist:<ul><li>patients with acne conglobate acne: a rare and severe form of acne found mostly in men that presents with extensive inflammatory papules, suppurative nodules (that may coalesce to form sinuses) and cysts on the trunk.</li><li>patients with nodulo-cystic acne</li></ul></li><li>referral should be <i>considered</i> in the following scenarios:<ul><li>mild to moderate acne has not responded to two completed courses of treatment</li><li>moderate to severe acne has not responded to previous treatment that includes an oral antibiotic</li><li>acne with <span class=\"concept\" data-cid=\"2618\">scarring</span></li><li>acne with <span class=\"concept\" data-cid=\"2618\">persistent pigmentary changes</span></li><li>acne is causing or contributing to persistent psychological distress or a mental health disorder</li></ul></li></ul>",
        "notes_hash": "7acbc55754b6e1e599a72a38c82e8f56",
        "knowledge_graph_node_id_link": 1352,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "5226",
        "up_votes": "49",
        "down_votes": "27",
        "column_array": [
            0,
            "155",
            "100",
            "526",
            "565",
            "3880",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/zxWh-7IC7HY\" data-description=\"Pharmacology - ACNE TREATMENTS\" data-upvotes=\"21\" data-downvotes=\"4\" data-media=\"1067\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/zxWh-7IC7HY/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/zxWh-7IC7HY\" data-description=\"Pharmacology - ACNE TREATMENTS\" data-upvotes=\"21\" data-downvotes=\"4\" data-media=\"1067\">Pharmacology - ACNE TREATMENTS</a></td></tr><tr><td><span ><small>Speed Pharmacology - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1861\" data-mediaid=\"1861\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1861\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">21</span><button type=\"button\" style=\"\" id=\"media_dislike_1861\" data-mediaid=\"1861\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1861\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr></table>",
        "comment_count": 3,
        "concepts_for_notes": {
            "957": {
                "concept_text": "Acne vulgaris in pregnancy - use oral erythromycin if treatment needed",
                "concept_percentile": "91"
            },
            "1117": {
                "concept_text": "For moderate-severe acne, one of the following should be used:\n   - topical adapalene with topical benzoyl peroxide \n   - topical tretinoin with topical clindamycin \n   - topical adapalene with topical benzoyl peroxide + either oral lymecycline or oral doxycycline\n   - topical azelaic acid + either oral lymecycline or oral doxycycline",
                "concept_percentile": "35"
            },
            "2622": {
                "concept_text": "Oral isotretinoin must only be used under specialist supervision",
                "concept_percentile": "54"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "2982_B_34",
        "new_question_id": "32537",
        "question_type": "0",
        "category": "9",
        "concept_id_link": "687",
        "notes_id_link": "1_408",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "A 'missed' stroke",
            "Cerebellar tumour",
            "Motor neurone disease",
            "Multiple sclerosis",
            "Parkinson's disease",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "You see a 60-year-old man in clinic.<br /><br />He says that in recent months he has had progressive slurred speech. This is embarrassing - as part of his job he often has to give presentations, some observers have joked that he sounds drunk.<br /><br />On examination of the head and face, there is no droop or drooling. However, the patient struggles to articulate certain phrases, such as 'British constitution', and finds it difficult to swallow a sip of water. When he sticks his tongue out, it seems to fasciculate.<br /><br />On examination of the limbs, there is general mild weakness and hypotonia. However, knees and ankles have slight hyperreflexia.<br /><br />What is the most likely cause of his presentation?",
            "",
            ""
        ],
        "answers": [
            "3",
            "0",
            "0"
        ],
        "notes": [
            "The combination of upper and motor neurone signs is suggestive of <b>motor neurone disease</b>. His slurred speech and swallowing difficulties could be due to bulbar palsy. In addition, tongue fasciculation has a relatively strong association with the condition.<br /><br />A <b>stroke</b> would typically present with sudden onset of neurological symptoms, rather than progressive symptoms over weeks or months like in this case.<br /><br />A <b>cerebellar tumour</b> may indeed cause progressive slurring of speech. However, this would usually be accompanied by other symptoms such as gait change (ataxia), vertigo (with nystagmus) and difficulty performing basic movements.<br /><br />A diagnosis of <b>multiple sclerosis</b> is uncommon in late-middle-aged men. Furthermore, it is an upper motor neurone disease, but this patient has a combination of upper and lower motor neurone signs.<br /><br />In the absence of a documented tremor or bradykinesia, <b>Parkinson's disease</b> is unlikely.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "You see a 60-year-old man in clinic.<br /><br />He says that in recent months he has had progressive slurred speech. This is embarrassing - as part of his job he often has to give presentations, some observers have joked that he sounds drunk.<br /><br />On examination of the head and face, there is no droop or drooling. However, the patient struggles to articulate certain phrases, such as 'British constitution', and finds it difficult to swallow a sip of water. When he sticks his tongue out, it seems to fasciculate.<br /><br />On examination of the limbs, there is general mild weakness and hypotonia. However, knees and ankles have slight hyperreflexia.<br /><br />What is the most likely cause of his presentation?",
        "correct_answer": "3",
        "question_notes": "The combination of upper and motor neurone signs is suggestive of <b>motor neurone disease</b>. His slurred speech and swallowing difficulties could be due to bulbar palsy. In addition, tongue fasciculation has a relatively strong association with the condition.<br /><br />A <b>stroke</b> would typically present with sudden onset of neurological symptoms, rather than progressive symptoms over weeks or months like in this case.<br /><br />A <b>cerebellar tumour</b> may indeed cause progressive slurring of speech. However, this would usually be accompanied by other symptoms such as gait change (ataxia), vertigo (with nystagmus) and difficulty performing basic movements.<br /><br />A diagnosis of <b>multiple sclerosis</b> is uncommon in late-middle-aged men. Furthermore, it is an upper motor neurone disease, but this patient has a combination of upper and lower motor neurone signs.<br /><br />In the absence of a documented tremor or bradykinesia, <b>Parkinson's disease</b> is unlikely.",
        "answer_order": "3",
        "answer": "3",
        "title": "Motor neuron disease: features",
        "body": "Motor neuron disease is a neurological condition of unknown cause which can present with both upper and lower motor neuron signs. It rarely presents before 40 years and various patterns of disease are recognised including amyotrophic lateral sclerosis (ALS), progressive muscular atrophy and bulbar palsy.<br /><br />There are a number of clues which point towards a diagnosis of motor neuron disease:<br /><ul><li>asymmetric limb weakness is the most common presentation of ALS</li><li>the <span class=\"concept\" data-cid=\"2360\">mixture of lower motor neuron and upper motor neuron signs</span></li><li>wasting of the small hand muscles/tibialis anterior is common</li><li><span class=\"concept\" data-cid=\"687\">fasciculations</span></li><li>the absence of sensory signs/symptoms<ul><li>vague sensory symptoms may occur early in the disease (e.g. limb pain) but 'never' sensory signs</li></ul></li></ul><br />Other features<br /><ul><li><span class=\"concept\" data-cid=\"8779\">doesn't affect external ocular muscles</span></li><li>no cerebellar signs</li><li>abdominal reflexes are usually preserved and sphincter dysfunction if present is a late feature</li></ul><br />The diagnosis of motor neuron disease is clinical, but nerve conduction studies will show <span class=\"concept\" data-cid=\"8092\">normal motor conduction</span> and can help exclude a neuropathy. Electromyography shows a reduced number of action potentials with increased amplitude. MRI is usually performed to exclude the differential diagnosis of cervical cord compression and myelopathy",
        "notes_hash": "06bd421b5516ec6336c1d468478cc5cf",
        "knowledge_graph_node_id_link": 1319,
        "concept": "'Fasciculations' - think motor neuron disease",
        "concept_percentile": "81",
        "concept_colour": "rgb(96,255,0)",
        "number_attempts": "6641",
        "up_votes": "26",
        "down_votes": "16",
        "column_array": [
            0,
            "178",
            "626",
            "5328",
            "333",
            "176",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Royal College of Physicians</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_613\" data-linkid=\"613\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_613\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">17</span><button type=\"button\" style=\"\" id=\"link_dislike_613\" data-linkid=\"613\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_613\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">17</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.rcpjournals.org/content/clinmedicine/13/1/97.full.pdf\">Motor neuron disease: diagnostic pitfalls</a></td></tr></table><br><br><table style='width:100%'><tr><td>Postgraduate Medical Journal</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1004\" data-linkid=\"1004\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1004\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">16</span><button type=\"button\" style=\"\" id=\"link_dislike_1004\" data-linkid=\"1004\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1004\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">14</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"http://pmj.bmjjournals.com/cgi/content/full/78/923/513\">Review of MND</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/dg_DntAnU8M\" data-description=\"Motor neuron disease\" data-upvotes=\"8\" data-downvotes=\"1\" data-media=\"1490\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/dg_DntAnU8M/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/dg_DntAnU8M\" data-description=\"Motor neuron disease\" data-upvotes=\"8\" data-downvotes=\"1\" data-media=\"1490\">Motor neuron disease</a></td></tr><tr><td><span ><small>Zero To Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2624\" data-mediaid=\"2624\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2624\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">8</span><button type=\"button\" style=\"\" id=\"media_dislike_2624\" data-mediaid=\"2624\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2624\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr></table>",
        "comment_count": 2,
        "concepts_for_notes": {
            "687": {
                "concept_text": "'Fasciculations' - think motor neuron disease",
                "concept_percentile": "81"
            },
            "8779": {
                "concept_text": "Eye movements are typically spared in motor neurone disease",
                "concept_percentile": "77"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1634_B_6",
        "new_question_id": "5628",
        "question_type": "0",
        "category": "1",
        "concept_id_link": "0",
        "notes_id_link": "1_1890",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Bisoprolol",
            "Amlodipine",
            "Omeprazole",
            "Simvastatin",
            "Ramipril",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 52-year-old man comes into the emergency department with his wife. He is unable to talk due to his tongue and lips being extensively swollen. His wife says that whilst they have been waiting these symptoms have become worse. She is unaware of what has caused this as he does not have any allergies but she knows that he has recently been started on a new medication by his GP. <br /><br />Which of the following medications is the most likely cause?",
            "",
            ""
        ],
        "answers": [
            "5",
            "",
            ""
        ],
        "notes": [
            "Given the mans age, it is possible that he could have been started on any of the medications listed, however he is clearly suffering from angioedema which can be noted by the swollen tongue and lips. <br /><br />Out of the possibilities, this side effect is most commonly associated with ACE inhibitors - in this case, ramipril.<br /><br />It is possible to develop angioedema despite having no previous allergies or previous adverse reactions to ACE inhibitors and although statistically the chances are low, due to the large numbers of patients on this type of medication and the potential complications that angioedema can cause, it should always be remembered.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 52-year-old man comes into the emergency department with his wife. He is unable to talk due to his tongue and lips being extensively swollen. His wife says that whilst they have been waiting these symptoms have become worse. She is unaware of what has caused this as he does not have any allergies but she knows that he has recently been started on a new medication by his GP. <br /><br />Which of the following medications is the most likely cause?",
        "correct_answer": "5",
        "question_notes": "Given the mans age, it is possible that he could have been started on any of the medications listed, however he is clearly suffering from angioedema which can be noted by the swollen tongue and lips. <br /><br />Out of the possibilities, this side effect is most commonly associated with ACE inhibitors - in this case, ramipril.<br /><br />It is possible to develop angioedema despite having no previous allergies or previous adverse reactions to ACE inhibitors and although statistically the chances are low, due to the large numbers of patients on this type of medication and the potential complications that angioedema can cause, it should always be remembered.",
        "answer_order": "5",
        "answer": "5",
        "title": "ACE inhibitors",
        "body": "Angiotensin-converting enzyme (ACE) inhibitors are now the established first-line treatment in younger patients with hypertension and are also extensively used to treat heart failure. They are known to be less effective in treating hypertensive Afro-Caribbean patients. ACE inhibitors are also used to treat diabetic nephropathy and have a role in the secondary prevention of ischaemic heart disease.<br /><br />Mechanism of action:<br /><ul><li>inhibits the conversion angiotensin I to angiotensin II<ul><li>&rarr; decrease in angiotensin II levels &rarr; to vasodilation and reduced blood pressure</li><li>&rarr; decrease in angiotensin II levels &rarr; reduced stimulation for aldosterone release &rarr; decrease in sodium and water retention by the kidneys</li></ul></li><li>renoprotective mechanism<ul><li>angiotensin II constricts the efferent glomerular arterioles </li><li>ACE inhibitors therefore lead to <span class=\"concept\" data-cid=\"12098\">dilation of the efferent arterioles</span> &rarr; reduced glomerular capillary pressure &rarr; decreased mechanical stress on the delicate filtration barriers of the glomeruli</li><li>this is particularly important in diabetic nephropathy</li></ul></li><li><span class=\"concept\" data-cid=\"5284\">ACE inhibitors are activated by phase 1 metabolism in the liver </span></li></ul><br />Side-effects:<br /><ul><li>cough<ul><li>occurs in around 15% of patients and may occur up to a year after starting treatment</li><li>thought to be due to <span class=\"concept\" data-cid=\"2034\">increased bradykinin levels</span></li></ul></li><li><span class=\"concept\" data-cid=\"2270\">angioedema</span>: may occur up to a year after starting treatment</li><li><span class=\"concept\" data-cid=\"5266\">hyperkalaemia</span></li><li>first-dose hypotension: more common in patients taking diuretics</li></ul><br />Cautions and contraindications<br /><ul><li><span class=\"concept\" data-cid=\"3346\">pregnancy</span> and breastfeeding - avoid</li><li><span class=\"concept\" data-cid=\"10496\">renovascular disease</span> - may result in renal impairment</li><li><span class=\"concept\" data-cid=\"3361\">aortic stenosis</span> - may result in hypotension</li><li>hereditary of idiopathic angioedema</li><li><span class=\"concept\" data-cid=\"10244\">specialist advice should be sought before starting ACE inhibitors in patients with a potassium >= 5.0 mmol/L</span></li></ul><br />Interactions<br /><ul><li>patients receiving high-dose diuretic therapy (more than 80 mg of furosemide a day)<ul><li>significantly increases the risk of hypotension</li></ul></li></ul><br />Monitoring<br /><ul><li><span class=\"concept\" data-cid=\"3883\">urea and electrolytes should be checked before treatment is initiated and after increasing the dose</span><ul><li>a rise in the creatinine and potassium may be expected after starting ACE inhibitors</li><li><span class=\"concept\" data-cid=\"3884\">acceptable changes are an increase in serum creatinine, up to 30% from baseline</span> and an increase in potassium up to 5.5 mmol/l.</li><li>significant renal impairment may occur in patients who have undiagnosed <span class=\"concept\" data-cid=\"10906\">bilateral renal artery stenosis</span></li></ul></li></ul><br />Examples of common ACE inhibitors<br /><ul><li>ramipril</li><li>enalapril</li><li>lisinopril</li></ul><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd566b.png'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd566.png'/></a></td></tr><tr><td valign='top' align='left'></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd566b.png'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><div class='imagetext'>Flow chart showing the management of hypertension as per current NICE guideliness</div>",
        "notes_hash": "b9bc8382b304704c258a375c1f412b6c",
        "knowledge_graph_node_id_link": 10620,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "6679",
        "up_votes": "51",
        "down_votes": "42",
        "column_array": [
            0,
            "265",
            "1859",
            "57",
            "229",
            "4269",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_471\" data-linkid=\"471\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_471\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">63</span><button type=\"button\" style=\"\" id=\"link_dislike_471\" data-linkid=\"471\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_471\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">41</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/cg182/chapter/1-recommendations\">2014 Chronic kidney disease guidelines</a></td></tr></table><br><br><table style='width:100%'><tr><td>BNF</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1747\" data-linkid=\"1747\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1747\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">62</span><button type=\"button\" style=\"\" id=\"link_dislike_1747\" data-linkid=\"1747\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1747\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">40</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://bnf.nice.org.uk/drug-class/angiotensin-converting-enzyme-inhibitors.html\">ACE inhibitors</a></td></tr></table>",
        "media": "",
        "comment_count": 6,
        "concepts_for_notes": {
            "2270": {
                "concept_text": "Drug-induced angioedema without urticaria is most frequently associated with angiotensin converting enzyme inhibitors or, less frequently, angiotensin II receptor blockers",
                "concept_percentile": "91"
            },
            "3883": {
                "concept_text": "Urea and electrolytes should be checked at baseline, within two weeks of initiation and after any change of dose. They should be rechecked at 1, 3, and 6 months after establishing maintenance dose",
                "concept_percentile": "37"
            },
            "3884": {
                "concept_text": "An increase in serum creatinine up to 30% from baseline is acceptable when initiating ACE inhibitor treatment",
                "concept_percentile": "83"
            },
            "5266": {
                "concept_text": "ACE inhibitor causes hyperkalaemia ",
                "concept_percentile": "57"
            },
            "10496": {
                "concept_text": "ACE inhibitors - contraindicated in patients with renovascular disease",
                "concept_percentile": "77"
            },
            "10906": {
                "concept_text": "After starting an ACE inhibitor, significant renal impairment may occur if the patient has undiagnosed bilateral renal artery stenosis",
                "concept_percentile": "89"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "2084_B_165",
        "new_question_id": "20980",
        "question_type": "0",
        "category": "0",
        "concept_id_link": "10373",
        "notes_id_link": "1_2333",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "He is over 16 and has capacity and therefore the mental capacity act does not apply",
            "He requires assessment under the mental health act (section 2) if he refuses treatment due given his dementia",
            "He should be treated under the concept of 'best interests' but allowed to decide on his care if he refuses medical advice  ",
            "He should be managed under the concept of 'best interests' unless he refuses treatment in which case he should be detained under the Mental Health Act  ",
            "He must be managed under the appropriate legal safeguards for deprivation of liberty regardless of his compliance with treatment, as he lacks capacity to consent  ",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 73-year-old man with a past medical history of vascular dementia is admitted to hospital with a community-acquired pneumonia requiring intravenous therapy. His abbreviated mental test score is 1/10 and he is unaware of why he is in hospital. He is not combative with staff and is complying with all treatments.<br /><br />What is the best way to manage this man with respect to his ability to consent for treatment?",
            "",
            ""
        ],
        "answers": [
            "5",
            "0",
            "0"
        ],
        "notes": [
            "This scenario is a common clinical situation involving an adult lacking capacity who requires inpatient treatment for a physical illness. The patient lacks capacity, as demonstrated by his low AMTS score and his unawareness of his hospital admission. Although he is compliant with treatment, he is effectively being deprived of his liberty due to continuous supervision in hospital and his inability to consent.<br /><br />In <b>England and Wales</b>, the appropriate framework is the <b>Mental Capacity Act (2005)</b> and the <b>Deprivation of Liberty Safeguards (DoLS)</b>. These ensure that individuals lacking capacity who are under continuous supervision and not free to leave are afforded legal protection, even if they are compliant with treatment. DoLS authorisation is necessary to ensure that any deprivation of liberty is lawful and in the person\u2019s best interests.<br /><br />The patient <b>cannot be treated solely under the concept of \u2018best interests\u2019</b> unless in an emergency situation. For ongoing care, legal safeguards such as DoLS (or their equivalent) must be applied.<br /><br />The <b>Mental Health Act</b> is not appropriate here. Section 2 is for assessment of mental health conditions and cannot be used for detaining a person in hospital solely for the treatment of a physical condition such as pneumonia.<br /><br /><b>The law in Scotland</b>  <br /><br />The <b>Mental Capacity Act and DoLS do not apply in Scotland</b>. Instead, similar safeguards are provided by the <b>Adults with Incapacity (Scotland) Act 2000</b>. Under this Act, treatment of adults who lack capacity is authorised using a <b>Section 47 certificate</b>, which permits healthcare professionals to treat in line with the patient's welfare. Where a deprivation of liberty is likely, additional legal steps may be needed, such as application for a <b>welfare guardianship order</b> or <b>court authorisation</b>.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 73-year-old man with a past medical history of vascular dementia is admitted to hospital with a community-acquired pneumonia requiring intravenous therapy. His abbreviated mental test score is 1/10 and he is unaware of why he is in hospital. He is not combative with staff and is complying with all treatments.<br /><br />What is the best way to manage this man with respect to his ability to consent for treatment?",
        "correct_answer": "5",
        "question_notes": "This scenario is a common clinical situation involving an adult lacking capacity who requires inpatient treatment for a physical illness. The patient lacks capacity, as demonstrated by his low AMTS score and his unawareness of his hospital admission. Although he is compliant with treatment, he is effectively being deprived of his liberty due to continuous supervision in hospital and his inability to consent.<br /><br />In <b>England and Wales</b>, the appropriate framework is the <b>Mental Capacity Act (2005)</b> and the <b>Deprivation of Liberty Safeguards (DoLS)</b>. These ensure that individuals lacking capacity who are under continuous supervision and not free to leave are afforded legal protection, even if they are compliant with treatment. DoLS authorisation is necessary to ensure that any deprivation of liberty is lawful and in the person\u2019s best interests.<br /><br />The patient <b>cannot be treated solely under the concept of \u2018best interests\u2019</b> unless in an emergency situation. For ongoing care, legal safeguards such as DoLS (or their equivalent) must be applied.<br /><br />The <b>Mental Health Act</b> is not appropriate here. Section 2 is for assessment of mental health conditions and cannot be used for detaining a person in hospital solely for the treatment of a physical condition such as pneumonia.<br /><br /><b>The law in Scotland</b>  <br /><br />The <b>Mental Capacity Act and DoLS do not apply in Scotland</b>. Instead, similar safeguards are provided by the <b>Adults with Incapacity (Scotland) Act 2000</b>. Under this Act, treatment of adults who lack capacity is authorised using a <b>Section 47 certificate</b>, which permits healthcare professionals to treat in line with the patient's welfare. Where a deprivation of liberty is likely, additional legal steps may be needed, such as application for a <b>welfare guardianship order</b> or <b>court authorisation</b>.",
        "answer_order": "5",
        "answer": "5",
        "title": "Deprivation of Liberty Safeguards",
        "body": "A key overview of the Deprivation of Liberty Safeguards (DOLS) legislation has been described by the The Social Care Institute for Excellence as the following:<br /><ul><li>The Deprivation of Liberty Safeguards are an amendment to the Mental Capacity Act 2005. They apply in England and Wales only.</li><li>The Mental Capacity Act allows restraint and restrictions to be used  but only if they are in a persons best interests.</li><li>Extra safeguards are needed if the restrictions and restraint used will deprive a person of their liberty. These are called the Deprivation of Liberty Safeguards.</li><li>The Deprivation of Liberty Safeguards can only be used if the person will be deprived of their liberty in a care home or hospital. In other settings the Court of Protection can be asked if a person can be deprived of their liberty.</li><li>Care homes or hospitals must ask either a local authority or health body if they can deprive a person of their liberty. This is called requesting a standard authorisation.</li><li>There are six assessments which have to take place before a standard authorisation can be given.</li><li>If a standard authorisation is given, one of the most important safeguards is that the person has someone appointed with legal powers to represent them. This is called the relevant persons representative and will usually be a family member or friend.</li><li>Other safeguards include rights to challenge authorisations in the Court of Protection without cost and access to independent mental capacity advocates (IMCAs).</li></ul>",
        "notes_hash": "d7b997e5d19b216fbb4e2d6e3d79e8c9",
        "knowledge_graph_node_id_link": 0,
        "concept": "A patient must be placed on a DOLS if they are to be treated in hospital and they do not have capacity to consent for this",
        "concept_percentile": "88",
        "concept_colour": "rgb(61,255,0)",
        "number_attempts": "966",
        "up_votes": "3",
        "down_votes": "1",
        "column_array": [
            0,
            "8",
            "103",
            "74",
            "164",
            "617",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>The Social Care Institute for Excellence</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_413\" data-linkid=\"413\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_413\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"link_dislike_413\" data-linkid=\"413\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_413\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"http://www.scie.org.uk/publications/ataglance/ataglance43.asp\">Deprivation of Liberty Safeguards</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/TYD19xh5W7M\" data-description=\"MCA: Deprivation of liberty. The Supreme Court judgment in practice\" data-upvotes=\"3\" data-downvotes=\"1\" data-media=\"682\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/TYD19xh5W7M/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/TYD19xh5W7M\" data-description=\"MCA: Deprivation of liberty. The Supreme Court judgment in practice\" data-upvotes=\"3\" data-downvotes=\"1\" data-media=\"682\">MCA: Deprivation of liberty. The Supreme Court judgment in practice</a></td></tr><tr><td><span ><small>Social Care Institute for Excellence - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1178\" data-mediaid=\"1178\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1178\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">3</span><button type=\"button\" style=\"\" id=\"media_dislike_1178\" data-mediaid=\"1178\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1178\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr></table>",
        "comment_count": 1,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "2633_B_84",
        "new_question_id": "14852",
        "question_type": "0",
        "category": "1",
        "concept_id_link": "3411",
        "notes_id_link": "1_560",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Unfractionated heparin",
            "Low molecular weight heparin",
            "Warfarin",
            "Aspirin",
            "Below-knee graduated compression stockings",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 24-year-old woman is admitted with unilateral calf pain and swelling. She is found to have an unprovoked DVT on Doppler ultrasound scan. She reports that she and her husband are very keen to start a family and plan to conceive within the following year. Which of the following medications is most suitable?",
            "",
            ""
        ],
        "answers": [
            "2",
            "0",
            "0"
        ],
        "notes": [
            "SIGN guidance recommends low molecular weight heparin (LMWH) as first line in treatment of venous thromboembolism (VTE) in pregnancy as it has a preferable safety profile as compared to unfractionated heparin and is equally effective.<br /><br />Below-knee compression stockings can also be used as an adjunct treatment.<br /><br />Vitamin K antagonists, like warfarin, are teratogenic and are contraindicated in pregnancy.<br /><br />Aspirin is not a treatment for VTE.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 24-year-old woman is admitted with unilateral calf pain and swelling. She is found to have an unprovoked DVT on Doppler ultrasound scan. She reports that she and her husband are very keen to start a family and plan to conceive within the following year. Which of the following medications is most suitable?",
        "correct_answer": "2",
        "question_notes": "SIGN guidance recommends low molecular weight heparin (LMWH) as first line in treatment of venous thromboembolism (VTE) in pregnancy as it has a preferable safety profile as compared to unfractionated heparin and is equally effective.<br /><br />Below-knee compression stockings can also be used as an adjunct treatment.<br /><br />Vitamin K antagonists, like warfarin, are teratogenic and are contraindicated in pregnancy.<br /><br />Aspirin is not a treatment for VTE.",
        "answer_order": "2",
        "answer": "2",
        "title": "Warfarin",
        "body": "Warfarin is an oral anticoagulant that was used first-line for many years in both the management of venous thromboembolism and reducing stroke risk in patients with atrial fibrillation. It has now been largely superseded by the use of direct oral anticoagulants (DOACs) which do not require the same level of monitoring as warfarin.<br /><br />Mechanism of action<br /><ul><li><span class=\"concept\" data-cid=\"9322\">inhibits epoxide reductase</span> preventing the reduction of vitamin K to its active hydroquinone form</li><li>this in turn acts as a cofactor in the carboxylation of clotting <span class=\"concept\" data-cid=\"748\">factor II, VII, IX and X (mnemonic = 1972)</span> and protein C.</li></ul><br />Indications<br /><ul><li>mechanical heart valves<ul><li>target INR depends on the valve type and location</li><li>mitral valves generally require a higher INR than aortic valves.</li></ul></li><li>second-line after DOACs:<ul><li>venous thromboembolism: target INR  = 2.5, if recurrent 3.5</li><li>atrial fibrillation, target INR = 2.5</li></ul></li></ul><br />Monitoring<br /><ul><li>patients are monitored using the INR (international normalised ratio), the ratio of the <span class=\"concept\" data-cid=\"9501\">prothrombin time</span> for the patient over the normal prothrombin time.</li><li>warfarin has a <span class=\"concept\" data-cid=\"11528\">long half-life</span> and achieving a stable INR may take several days</li><li>there are a variety of loading regimes and computer software is now often used to alter the dose</li></ul><br />Factors that may potentiate warfarin<br /><ul><li>liver disease</li><li>P450 enzyme inhibitors, e.g.: amiodarone, ciprofloxacin</li><li>cranberry juice</li><li>drugs which displace warfarin from plasma albumin, e.g. NSAIDs</li><li>inhibit platelet function: NSAIDs</li></ul><br />Side-effects<br /><ul><li>haemorrhage</li><li><span class=\"concept\" data-cid=\"3411\">teratogenic</span>, although <span class=\"concept\" data-cid=\"6065\">can be used in breastfeeding mothers</span></li><li>skin necrosis<ul><li>when warfarin is first started biosynthesis of protein C is reduced</li><li>this results in a temporary procoagulant state after initially starting warfarin, normally avoided by concurrent heparin administration</li><li>thrombosis may occur in venules leading to skin necrosis</li></ul></li><li>purple toes</li></ul>",
        "notes_hash": "b5f96b209202dc682bcc3ea9a1103386",
        "knowledge_graph_node_id_link": 10824,
        "concept": "Warfarin is teratogenic",
        "concept_percentile": "66",
        "concept_colour": "rgb(173,255,0)",
        "number_attempts": "6127",
        "up_votes": "37",
        "down_votes": "27",
        "column_array": [
            0,
            "472",
            "4876",
            "432",
            "239",
            "108",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>British Journal of Hematology</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1365\" data-linkid=\"1365\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1365\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">8</span><button type=\"button\" style=\"\" id=\"link_dislike_1365\" data-linkid=\"1365\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1365\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">11</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://onlinelibrary.wiley.com/doi/full/10.1111/bjh.14344\">Peri-Operative Management of Anticoagulation and Antiplatelet Therapy 2016</a></td></tr></table><br><br><table style='width:100%'><tr><td>BNF</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1493\" data-linkid=\"1493\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1493\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">9</span><button type=\"button\" style=\"\" id=\"link_dislike_1493\" data-linkid=\"1493\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1493\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">6</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://bnf.nice.org.uk/treatment-summary/oral-anticoagulants.html\">Oral anticoagulants</a></td></tr></table><br><br><table style='width:100%'><tr><td>DermnetNZ</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1134\" data-linkid=\"1134\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1134\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">14</span><button type=\"button\" style=\"\" id=\"link_dislike_1134\" data-linkid=\"1134\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1134\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">8</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.dermnetnz.org/topics/warfarin-induced-skin-necrosis/\"> Warfarin induced skin necrosis</a></td></tr></table><br><br><table style='width:100%'><tr><td>BNF</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1133\" data-linkid=\"1133\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1133\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">9</span><button type=\"button\" style=\"\" id=\"link_dislike_1133\" data-linkid=\"1133\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1133\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://bnf.nice.org.uk/drug/warfarin-sodium.html\">Warfarin</a></td></tr></table><br><br><table style='width:100%'><tr><td>British Committee for Standards in Haematology</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1135\" data-linkid=\"1135\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1135\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">24</span><button type=\"button\" style=\"\" id=\"link_dislike_1135\" data-linkid=\"1135\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1135\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2011.08753.x/full\">Guidelines on oral anticoagulation (warfarin): fourth edition - 2011 update</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ys8fMaqfq4Q\" data-description=\"Haemostasis 3 - Anticoagulants & Thrombolytics\" data-upvotes=\"7\" data-downvotes=\"1\" data-media=\"164\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/ys8fMaqfq4Q/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ys8fMaqfq4Q\" data-description=\"Haemostasis 3 - Anticoagulants & Thrombolytics\" data-upvotes=\"7\" data-downvotes=\"1\" data-media=\"164\">Haemostasis 3 - Anticoagulants & Thrombolytics</a></td></tr><tr><td><span ><small>Handwritten Tutorials - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_282\" data-mediaid=\"282\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_282\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">7</span><button type=\"button\" style=\"\" id=\"media_dislike_282\" data-mediaid=\"282\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_282\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/eZBtQ0rDnG4\" data-description=\"Anticoagulants and antiplatelets\" data-upvotes=\"0\" data-downvotes=\"1\" data-media=\"626\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/eZBtQ0rDnG4/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/eZBtQ0rDnG4\" data-description=\"Anticoagulants and antiplatelets\" data-upvotes=\"0\" data-downvotes=\"1\" data-media=\"626\">Anticoagulants and antiplatelets</a></td></tr><tr><td><span ><small>Speed Pharmacology - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1068\" data-mediaid=\"1068\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1068\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_1068\" data-mediaid=\"1068\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1068\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr></table>",
        "comment_count": 7,
        "concepts_for_notes": {
            "3411": {
                "concept_text": "Warfarin is teratogenic",
                "concept_percentile": "66"
            },
            "6065": {
                "concept_text": "Warfarin in breastfeeding  is considered safe to use",
                "concept_percentile": "23"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_569",
        "new_question_id": "7566",
        "question_type": "0",
        "category": "1",
        "concept_id_link": "0",
        "notes_id_link": "1_259",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Ramipril",
            "Losartan",
            "Bendroflumethiazide",
            "Amlodipine",
            "Atenolol",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 74-year-old man presents to his GP for a medication review. Blood pressure is recorded as 184/72. This is confirmed on two further occasions. What is the most appropriate first line therapy?",
            "",
            ""
        ],
        "answers": [
            "4",
            "",
            ""
        ],
        "notes": [
            "The 2011 NICE guidelines recommended treating isolated systolic hypertension the same way as standard hypertension. In this age group calcium channel blockers would be first-line.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 74-year-old man presents to his GP for a medication review. Blood pressure is recorded as 184/72. This is confirmed on two further occasions. What is the most appropriate first line therapy?",
        "correct_answer": "4",
        "question_notes": "The 2011 NICE guidelines recommended treating isolated systolic hypertension the same way as standard hypertension. In this age group calcium channel blockers would be first-line.",
        "answer_order": "4",
        "answer": "4",
        "title": "Isolated systolic hypertension",
        "body": "Isolated systolic hypertension (ISH) is common in the elderly, affecting around 50% of people older than 70 years old. The Systolic Hypertension in the Elderly Program (SHEP) back in 1991 established that treating ISH reduced both strokes and ischaemic heart disease. Drugs such as thiazides were recommended as first line agents. This approach is contradicated by the 2011 NICE guidelines which recommends treating ISH in the same stepwise fashion as standard hypertension.",
        "notes_hash": "a918513b31690fa0b4c7b9ed88a4b3c1",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "8347",
        "up_votes": "39",
        "down_votes": "11",
        "column_array": [
            0,
            "1090",
            "152",
            "33",
            "7023",
            "49",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_108\" data-linkid=\"108\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_108\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">11</span><button type=\"button\" style=\"\" id=\"link_dislike_108\" data-linkid=\"108\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_108\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng136/chapter/Recommendations\">2019 Hypertension guidelines</a></td></tr></table>",
        "media": "",
        "comment_count": 1,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "24040_B_109",
        "new_question_id": "39007",
        "question_type": "0",
        "category": "6",
        "concept_id_link": "11269",
        "notes_id_link": "1_776",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Increased forward flexion",
            "Increased lateral flexion",
            "Localised spinal tenderness",
            "Reduced chest expansion",
            "Saddle anaesthesia",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 22-year-old man presents to the GP with recurrent lower back pain over the last 9 months. He states that his back is painful and stiff upon waking and lasts for 2-3 hours and improves throughout the day.<br /><br />His past medical history is significant for Achilles tendonitis which has been treated successfully.<br /><br />What clinical finding on examination would support the likely diagnosis?",
            "",
            ""
        ],
        "answers": [
            "4",
            "0",
            "0"
        ],
        "notes": [
            "<b>Reduced chest expansion</b> is correct. The back pain this patient is experiencing is likely to be inflammatory in nature due to the pain and stiffness being worse and prolonged in the morning and improving throughout the day. Young men with inflammatory-like back pain should raise suspicion of ankylosing spondylitis (AS). A complication of AS can be Achilles tendonitis, which is what may have been the cause of it in this patient in the past. Due to rib involvement, AS can lead to reduced chest expansion as it can lead to breathing discomfort and taking shallower breaths over time. This can lead to scarring and a reduction in the chest's ability to expand fully.<br /><br /><b>Increased forward flexion</b> is incorrect. A reduction in forward flexion can be found on clinical examination due to the inflammatory condition decreasing flexibility, not increased forward flexion.<br /><br /><b>Increased lateral flexion</b> is incorrect. The decreased flexibility from inflammation of the spine results in a reduction in lateral flexion, not an increase.<br /><br /><b>Localised spinal tenderness</b> is incorrect. If this was present, a malignancy or fracture should be suspected. It is unusual for examination to elicit localised tenderness in ankylosing spondylitis.<br /><br /><b>Saddle anaesthesia</b> is incorrect. This is a key symptom in diagnosing cauda equina syndrome. Other signs that indicate this diagnosis include urinary retention, faecal incontinence, and bilateral sciatica which imply a surgical emergency and warrant immediate intervention. It is not seen in ankylosing spondylitis.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 22-year-old man presents to the GP with recurrent lower back pain over the last 9 months. He states that his back is painful and stiff upon waking and lasts for 2-3 hours and improves throughout the day.<br /><br />His past medical history is significant for Achilles tendonitis which has been treated successfully.<br /><br />What clinical finding on examination would support the likely diagnosis?",
        "correct_answer": "4",
        "question_notes": "<b>Reduced chest expansion</b> is correct. The back pain this patient is experiencing is likely to be inflammatory in nature due to the pain and stiffness being worse and prolonged in the morning and improving throughout the day. Young men with inflammatory-like back pain should raise suspicion of ankylosing spondylitis (AS). A complication of AS can be Achilles tendonitis, which is what may have been the cause of it in this patient in the past. Due to rib involvement, AS can lead to reduced chest expansion as it can lead to breathing discomfort and taking shallower breaths over time. This can lead to scarring and a reduction in the chest's ability to expand fully.<br /><br /><b>Increased forward flexion</b> is incorrect. A reduction in forward flexion can be found on clinical examination due to the inflammatory condition decreasing flexibility, not increased forward flexion.<br /><br /><b>Increased lateral flexion</b> is incorrect. The decreased flexibility from inflammation of the spine results in a reduction in lateral flexion, not an increase.<br /><br /><b>Localised spinal tenderness</b> is incorrect. If this was present, a malignancy or fracture should be suspected. It is unusual for examination to elicit localised tenderness in ankylosing spondylitis.<br /><br /><b>Saddle anaesthesia</b> is incorrect. This is a key symptom in diagnosing cauda equina syndrome. Other signs that indicate this diagnosis include urinary retention, faecal incontinence, and bilateral sciatica which imply a surgical emergency and warrant immediate intervention. It is not seen in ankylosing spondylitis.",
        "answer_order": "4",
        "answer": "4",
        "title": "Ankylosing spondylitis: features",
        "body": "Ankylosing spondylitis is a HLA-B27 associated spondyloarthropathy. It typically presents in males (sex ratio 3:1) aged 20-30 years old.<br /><br /><span class=\"concept\" data-cid=\"11268\">Features</span><br /><ul><li>typically a young man who presents with lower back pain and stiffness of insidious onset</li><li>stiffness is usually worse in the morning and <span class=\"concept\" data-cid=\"11796\">improves with exercise</span></li><li>the patient may experience pain at night which improves on getting up</li></ul><br /><span class=\"concept\" data-cid=\"11269\">Clinical examination</span><br /><ul><li>reduced lateral flexion</li><li>reduced forward flexion - Schober's test - a line is drawn 10 cm above and 5 cm below the back dimples (dimples of Venus). The distance between the two lines should increase by more than 5 cm when the patient bends as far forward as possible</li><li>reduced chest expansion</li></ul><br />Other features - <span class=\"concept\" data-cid=\"856\">the 'A's</span> <br /><ul><li>Apical fibrosis</li><li><span class=\"concept\" data-cid=\"2662\">Anterior uveitis</span></li><li>Aortic regurgitation</li><li>Achilles tendonitis</li><li>AV node block</li><li>Amyloidosis</li><li>and cauda equina syndrome</li><li>peripheral arthritis (25%, more common if female)</li></ul>",
        "notes_hash": "ce36d675bfefc6f3fcfb2270b58f581e",
        "knowledge_graph_node_id_link": 1061,
        "concept": "Clinical findings in anylosing spondylitis include reduced chest expansion, reduced lateral flexion and reduced forward flexion (Schober's test)",
        "concept_percentile": "74",
        "concept_colour": "rgb(132,255,0)",
        "number_attempts": "4771",
        "up_votes": "22",
        "down_votes": "23",
        "column_array": [
            0,
            "684",
            "460",
            "1074",
            "2443",
            "110",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1574\" data-linkid=\"1574\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1574\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">8</span><button type=\"button\" style=\"\" id=\"link_dislike_1574\" data-linkid=\"1574\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1574\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">7</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng65/chapter/Recommendations\">2017 Spondyloarthritis in over 16s: diagnosis and management</a></td></tr></table><br><br><table style='width:100%'><tr><td>Arthritis Reasearch Council</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_405\" data-linkid=\"405\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_405\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">7</span><button type=\"button\" style=\"\" id=\"link_dislike_405\" data-linkid=\"405\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_405\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">6</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.versusarthritis.org/about-arthritis/conditions/ankylosing-spondylitis/\">Ankylosing Spondylitis Patient Info</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/XJZUUgrpFoo\" data-description=\"Ankylosing spondylitis\" data-upvotes=\"6\" data-downvotes=\"0\" data-media=\"1276\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/XJZUUgrpFoo/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/XJZUUgrpFoo\" data-description=\"Ankylosing spondylitis\" data-upvotes=\"6\" data-downvotes=\"0\" data-media=\"1276\">Ankylosing spondylitis</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2255\" data-mediaid=\"2255\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2255\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">6</span><button type=\"button\" style=\"\" id=\"media_dislike_2255\" data-mediaid=\"2255\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2255\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/a23A3nAaO0E\" data-description=\"Ankylosing spondylitis\" data-upvotes=\"11\" data-downvotes=\"1\" data-media=\"877\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/a23A3nAaO0E/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/a23A3nAaO0E\" data-description=\"Ankylosing spondylitis\" data-upvotes=\"11\" data-downvotes=\"1\" data-media=\"877\">Ankylosing spondylitis</a></td></tr><tr><td><span ><small>Zero to Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1536\" data-mediaid=\"1536\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1536\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">11</span><button type=\"button\" style=\"\" id=\"media_dislike_1536\" data-mediaid=\"1536\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1536\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/WVGrOgOn3v0\" data-description=\"Ankylosing spondylitis\" data-upvotes=\"1\" data-downvotes=\"2\" data-media=\"1423\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/WVGrOgOn3v0/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/WVGrOgOn3v0\" data-description=\"Ankylosing spondylitis\" data-upvotes=\"1\" data-downvotes=\"2\" data-media=\"1423\">Ankylosing spondylitis</a></td></tr><tr><td><span ><small>Townsend Teaching - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2501\" data-mediaid=\"2501\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2501\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1</span><button type=\"button\" style=\"\" id=\"media_dislike_2501\" data-mediaid=\"2501\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2501\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 1,
        "concepts_for_notes": {
            "856": {
                "concept_text": "Ankylosing spondylitis features - the 'A's \r\n   - Apical fibrosis\r\n   - Anterior uveitis\r\n   - Aortic regurgitation\r\n   - Achilles tendonitis\r\n   - AV node block\r\n   - Amyloidosis",
                "concept_percentile": "56"
            },
            "11269": {
                "concept_text": "Clinical findings in anylosing spondylitis include reduced chest expansion, reduced lateral flexion and reduced forward flexion (Schober's test)",
                "concept_percentile": "74"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "5592_B_245",
        "new_question_id": "29707",
        "question_type": "0",
        "category": "9",
        "concept_id_link": "4236",
        "notes_id_link": "1_271",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Alzheimer's dementia",
            "Creutzfeldt-Jakob disease",
            "Frontotemporal dementia",
            "Lewy body dementia",
            "Vascular dementia",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 64-year-old man is seen in the memory clinic with an 8-month history of cognitive decline. His wife tells you that he has difficulty remembering basic tasks and is becoming more confused and forgetful than usual. She has also noticed a change in his personality and has caught him swearing more frequently and answering the door naked on multiple occasions. His mother had a similar reputation for being 'too outspoken' in her twilight years. He reports smoking 20 cigarettes/day and drinks 1 glass of wine each evening. <br /><br />What is the most likely diagnosis?",
            "",
            ""
        ],
        "answers": [
            "3",
            "0",
            "0"
        ],
        "notes": [
            "This patient has frontotemporal lobar degeneration (FTLD). There are 3 subtypes of FTLD including frontotemporal dementia (or Pick's disease), progressive non-fluent aphasia, and semantic dementia. Of the 3 subtypes, this patient has Pick's disease which is characterised by an insidious onset, commonly before 65 years, and a change in personality and social disinhibition. The positive family history also makes frontotemporal dementia more likely. <br /><br />Alzheimer's disease is the most common type of dementia. However, unlike this presentation, Alzheimer's dementia presents as a progressive decline in episodic memory. Visuospatial awareness may be impacted. Social disinhibition is not a common presenting feature and suggests an alternative diagnosis.<br /><br />Creutzfeldt-Jakob disease is a very rare condition. It is a type of prion disease that causes rapid and progressive neurodegeneration. Cognitive decline and personality change are features. However, typically additional symptoms such as abnormal jerking movements, loss of coordination, mobility, vision and slurred speech are also present. <br /><br />Lewy body dementia is a type of dementia characterised by fluctuating confusion and hallucinations. There is an overlap with Parkinson's disease and motor symptoms may also be seen such as bradykinesia, tremor and a shuffling gait.<br /><br />Vascular dementia is a type of dementia that follows a step-wise progression. Symptoms tend to vary depending on the areas of the brain affected by vascular disease. However, the degree of social disinhibition and positive family history in this case presentation makes vascular dementia less likely.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 64-year-old man is seen in the memory clinic with an 8-month history of cognitive decline. His wife tells you that he has difficulty remembering basic tasks and is becoming more confused and forgetful than usual. She has also noticed a change in his personality and has caught him swearing more frequently and answering the door naked on multiple occasions. His mother had a similar reputation for being 'too outspoken' in her twilight years. He reports smoking 20 cigarettes/day and drinks 1 glass of wine each evening. <br /><br />What is the most likely diagnosis?",
        "correct_answer": "3",
        "question_notes": "This patient has frontotemporal lobar degeneration (FTLD). There are 3 subtypes of FTLD including frontotemporal dementia (or Pick's disease), progressive non-fluent aphasia, and semantic dementia. Of the 3 subtypes, this patient has Pick's disease which is characterised by an insidious onset, commonly before 65 years, and a change in personality and social disinhibition. The positive family history also makes frontotemporal dementia more likely. <br /><br />Alzheimer's disease is the most common type of dementia. However, unlike this presentation, Alzheimer's dementia presents as a progressive decline in episodic memory. Visuospatial awareness may be impacted. Social disinhibition is not a common presenting feature and suggests an alternative diagnosis.<br /><br />Creutzfeldt-Jakob disease is a very rare condition. It is a type of prion disease that causes rapid and progressive neurodegeneration. Cognitive decline and personality change are features. However, typically additional symptoms such as abnormal jerking movements, loss of coordination, mobility, vision and slurred speech are also present. <br /><br />Lewy body dementia is a type of dementia characterised by fluctuating confusion and hallucinations. There is an overlap with Parkinson's disease and motor symptoms may also be seen such as bradykinesia, tremor and a shuffling gait.<br /><br />Vascular dementia is a type of dementia that follows a step-wise progression. Symptoms tend to vary depending on the areas of the brain affected by vascular disease. However, the degree of social disinhibition and positive family history in this case presentation makes vascular dementia less likely.",
        "answer_order": "3",
        "answer": "3",
        "title": "Frontotemporal lobar degeneration",
        "body": "Frontotemporal lobar degeneration (FTLD) is the third most common type of cortical dementia after Alzheimer's and Lewy body dementia. <br /><br />There are three recognised types of FTLD<br /><ul><li>Frontotemporal dementia (Pick's disease)</li><li>Progressive non fluent aphasia (chronic progressive aphasia, CPA)</li><li>Semantic dementia</li></ul><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b>Common features of frontotemporal lobar dementias</b></th></tr></thead><tbody><tr><td>Onset before 65</td></tr><tr><td>\tInsidious onset</td></tr><tr><td>\tRelatively preserved memory and visuospatial skills</td></tr><tr><td>\tPersonality change and social conduct problems</td></tr></tbody></table></div><br /><h5 class='notes-heading'>Pick's disease</h5><br />This is the most common type and is characterised by <span class=\"concept\" data-cid=\"5070\">personality change and impaired social conduct</span>.  Other common features include hyperorality, disinhibition, increased appetite, and perseveration behaviours.<br /><br />Focal gyral atrophy with a knife-blade appearance is characteristic of Pick's disease.<br /><br />Macroscopic changes seen in Pick's disease include:-<br /><ul><li>Atrophy of the frontal and temporal lobes</li></ul><br />Microscopic changes include:-<br /><ul><li>Pick bodies - spherical aggregations of tau protein (silver-staining)</li><li>Gliosis</li><li>Neurofibrillary tangles</li><li>Senile plaques</li></ul><br />Management<br /><ul><li>NICE do not recommend that AChE inhibitors or memantine are used in people with frontotemporal dementia</li></ul><br /><h5 class='notes-heading'>CPA</h5><br />Here the chief factor is non fluent speech.  They make short utterances that are agrammatic. Comprehension is relatively preserved.<br /><br /><h5 class='notes-heading'>Semantic dementia</h5><br />Here the patient has a fluent progressive aphasia.  The speech is fluent but empty and conveys little meaning.  Unlike in Alzheimer's memory is better for recent rather than remote events.",
        "notes_hash": "570b8aa61b32fb2de4e8b9154ad22b62",
        "knowledge_graph_node_id_link": 1268,
        "concept": "Frontotemporal dementia presents with social disinhibition and often has a family history",
        "concept_percentile": "65",
        "concept_colour": "rgb(178,255,0)",
        "number_attempts": "6149",
        "up_votes": "23",
        "down_votes": "10",
        "column_array": [
            0,
            "315",
            "65",
            "4943",
            "369",
            "457",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/gKZhp2JNYyI\" data-description=\"Understanding Dementia (Alzheimer's & Vascular & Frontotemporal & Lewy Body Dementia)\" data-upvotes=\"2\" data-downvotes=\"1\" data-media=\"1366\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/gKZhp2JNYyI/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/gKZhp2JNYyI\" data-description=\"Understanding Dementia (Alzheimer's & Vascular & Frontotemporal & Lewy Body Dementia)\" data-upvotes=\"2\" data-downvotes=\"1\" data-media=\"1366\">Understanding Dementia (Alzheimer's & Vascular & Frontotemporal & Lewy Body Dementia)</a></td></tr><tr><td><span ><small>Rhesus Medicine - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2402\" data-mediaid=\"2402\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2402\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_2402\" data-mediaid=\"2402\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2402\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr></table>",
        "comment_count": 3,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_648",
        "new_question_id": "10528",
        "question_type": "0",
        "category": "12",
        "concept_id_link": "0",
        "notes_id_link": "1_836",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Home nebulisers",
            "Tiotropium inhaler",
            "Long-term steroid therapy",
            "Smoking cessation",
            "Long-term oxygen therapy",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "Which one of the following interventions is most likely to increase survival in patients with COPD?",
            "",
            ""
        ],
        "answers": [
            "4",
            "",
            ""
        ],
        "notes": [
            "Whilst long-term oxygen therapy may increase survival in hypoxic patients, smoking cessation is the single most important intervention in patients with COPD",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "Which one of the following interventions is most likely to increase survival in patients with COPD?",
        "correct_answer": "4",
        "question_notes": "Whilst long-term oxygen therapy may increase survival in hypoxic patients, smoking cessation is the single most important intervention in patients with COPD",
        "answer_order": "4",
        "answer": "4",
        "title": "COPD: stable management",
        "body": "NICE updated its guidelines on the management of chronic obstructive pulmonary disease (COPD) in 2018.<br /><br />General management<br /><ul><li><span class=\"concept\" data-cid=\"4006\">>smoking cessation</span> advice: including offering nicotine replacement therapy, varenicline or bupropion</li><li>annual influenza vaccination</li><li>one-off pneumococcal vaccination</li><li><span class=\"concept\" data-cid=\"3990\">pulmonary rehabilitation</span> to all people who view themselves as functionally disabled by COPD (usually Medical Research Council [MRC] grade 3 and above)</li></ul><br />Bronchodilator therapy<br /><ul><li><span class=\"concept\" data-cid=\"1499\">a short-acting beta2-agonist (SABA) or short-acting muscarinic antagonist (SAMA) is first-line treatment</span></li><li>for patients who remain breathless or have exacerbations despite using short-acting bronchodilators the next step is determined by whether the patient has <i>'asthmatic features/features suggesting steroid responsiveness'</i></li></ul><br />There are a <span class=\"concept\" data-cid=\"9525\">number of criteria NICE suggest to determine whether a patient has asthmatic/steroid responsive features:</span><br /><ul><li>any previous, secure diagnosis of asthma or of atopy</li><li>a higher blood eosinophil count - note that NICE recommend a full blood count for all patients as part of the work-up</li><li>substantial variation in FEV1 over time (at least 400 ml)</li><li>substantial diurnal variation in peak expiratory flow (at least 20%)</li></ul><br />Interestingly NICE do not recommend formal reversibility testing as one of the criteria. In the guidelines they state that <i>'routine spirometric reversibility testing is not necessary as part of the diagnostic process or to plan initial therapy with bronchodilators or corticosteroids. It may be unhelpful or misleading...'</i>. They then go on to discuss why they have reached this conclusion. Please see the guidelines for more details.<br /><br />No asthmatic features/features suggesting steroid responsiveness<br /><ul><li><span class=\"concept\" data-cid=\"889\">add a long-acting beta2-agonist (LABA) + long-acting muscarinic antagonist (LAMA)</span><ul><li><span class=\"concept\" data-cid=\"7723\">if already taking a SAMA, discontinue and switch to a SABA</span></li></ul></li></ul><br />Asthmatic features/features suggesting steroid responsiveness<br /><ul><li><span class=\"concept\" data-cid=\"890\">LABA + inhaled corticosteroid (ICS)</span></li><li>if patients remain breathless or have exacerbations offer <span class=\"concept\" data-cid=\"7505\">triple therapy i.e. LAMA + LABA + ICS</span><ul><li><span class=\"concept\" data-cid=\"7723\">if already taking a SAMA, discontinue and switch to a SABA</span></li></ul></li><li>NICE recommend the use of combined inhalers where possible</li><li>NICE specifically mention the <span class=\"concept\" data-cid=\"12493\">risk of pneumonia</span> in patients with COPD using inhaled corticosteroids</li></ul><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd542b.png\" data-fancybox=\"gallery\" data-caption=\"NICE 2018 COPD guidelines - simplified flowchart\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd542.png\" alt=\"\" /></a></div></div></div><br />Oral theophylline<br /><ul><li>NICE only recommends theophylline after trials of short and long-acting bronchodilators or to people who cannot used inhaled therapy</li><li>the dose should be reduced if macrolide or fluoroquinolone antibiotics are co-prescribed</li></ul><br />Oral prophylactic antibiotic therapy<br /><ul><li><span class=\"concept\" data-cid=\"9761\">azithromycin prophylaxis is recommended in select patients</span></li><li>patients <span class=\"concept\" data-cid=\"10638\">should not smoke</span>, have optimised standard treatments and continue to have exacerbations</li><li>other prerequisites include a CT thorax (to exclude bronchiectasis) and sputum culture (to exclude atypical infections and tuberculosis)</li><li>LFTs and an <span class=\"concept\" data-cid=\"9526\">ECG to exclude QT prolongation should also be done as azithromycin can prolong the QT interval</span></li></ul><br /><span class=\"concept\" data-cid=\"12253\">Standby medication: NICE recommend offering a short course of oral corticosteroids and oral antibiotics</span> to keep at home if:  <a href='https://www.nice.org.uk/guidance/ng115/chapter/Recommendations#managing-stable-copd:~:text=Offer%20people%20a%20short%20course%20of%20oral%20corticosteroids%20and%20a%20short%20course%20of%20oral%20antibiotics%20to%20keep%20at%20home%20as%20part%20of%20their%20exacerbation%20action%20plan%20if%3A' title='NICE - 2018 COPD guidelines' target='_blank' class='badge rounded-pill text-bg-light deeplink'>NICE</a> <br /><ul><li>have had an exacerbation within the last year</li><li>understand how to take the medication, and are aware of associated risks and benefits</li><li>know to when to seek help and when to ask for replacements once medication has been used</li></ul><br />Mucolytics<br /><ul><li>should be 'considered' in patients with a chronic productive cough and continued if symptoms improve</li></ul><br /><span class=\"concept\" data-cid=\"12077\">Phosphodiesterase-4 (PDE-4) inhibitors</span>  <a href='https://www.nice.org.uk/guidance/ta461/chapter/1-Recommendations#:~:text=1-,Recommendations,-1.1' title='NICE - Roflumilast NICE recommendations' target='_blank' class='badge rounded-pill text-bg-light deeplink'>NICE</a> <br /><ul><li>oral PDE-4 inhibitors such as roflumilast reduce the risk of COPD exacerbations in patients with severe COPD and a history of frequent COPD exacerbations</li><li>NICE recommend if:<ul><li>the disease is severe, defined as a forced expiratory volume in 1 second (FEV1) after a bronchodilator of less than 50% of predicted normal, and</li><li>the person has had 2 or more exacerbations in the previous 12 months despite triple inhaled therapy with a long-acting muscarinic antagonist, a long-acting beta-2 agonist and an inhaled corticosteroid</li></ul></li></ul><br />Cor pulmonale<br /><ul><li>features include peripheral oedema, raised jugular venous pressure, systolic parasternal heave, loud P2</li><li>use a loop diuretic for oedema, consider long-term oxygen therapy</li><li>ACE-inhibitors, calcium channel blockers and alpha blockers are not recommended by NICE</li></ul><br />Factors which may improve survival in patients with stable COPD<br /><ul><li>smoking cessation - the single most important intervention in patients who are still smoking </li><li>long term oxygen therapy in patients who fit criteria </li><li>lung volume reduction surgery in selected patients</li></ul>",
        "notes_hash": "1b3e15be8109654eb018de2330833108",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "6442",
        "up_votes": "58",
        "down_votes": "38",
        "column_array": [
            0,
            "11",
            "34",
            "111",
            "4496",
            "1790",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Global Initiative for Chronic Obstructive Lung Disease</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_40\" data-linkid=\"40\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_40\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">25</span><button type=\"button\" style=\"\" id=\"link_dislike_40\" data-linkid=\"40\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_40\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">39</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://goldcopd.org/\">GOLD criteria 2017</a></td></tr></table><br><br><table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1362\" data-linkid=\"1362\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1362\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">19</span><button type=\"button\" style=\"\" id=\"link_dislike_1362\" data-linkid=\"1362\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1362\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">21</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/TA461/chapter/1-Recommendations\">Roflumilast NICE recommendations</a></td></tr></table><br><br><table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1202\" data-linkid=\"1202\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1202\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">35</span><button type=\"button\" style=\"\" id=\"link_dislike_1202\" data-linkid=\"1202\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1202\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">33</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng115/chapter/Recommendations\">2018 COPD guidelines</a></td></tr></table><br><br><table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1429\" data-linkid=\"1429\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1429\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">50</span><button type=\"button\" style=\"\" id=\"link_dislike_1429\" data-linkid=\"1429\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1429\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">16</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng115/resources/visual-summary-treatment-algorithm-pdf-6604261741\">2018 COPD management diagram</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/f/f3/Chronic_bronchitis.webm\" data-description=\"Chronic bronchitis\" data-upvotes=\"3\" data-downvotes=\"1\" data-media=\"984\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/css/images/osmosis.png\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/f/f3/Chronic_bronchitis.webm\" data-description=\"Chronic bronchitis\" data-upvotes=\"3\" data-downvotes=\"1\" data-media=\"984\">Chronic bronchitis</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1710\" data-mediaid=\"1710\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1710\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">3</span><button type=\"button\" style=\"\" id=\"media_dislike_1710\" data-mediaid=\"1710\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1710\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/GGkajjvMEAQ\" data-description=\"Cor pulmonale\" data-upvotes=\"8\" data-downvotes=\"3\" data-media=\"1291\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/GGkajjvMEAQ/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/GGkajjvMEAQ\" data-description=\"Cor pulmonale\" data-upvotes=\"8\" data-downvotes=\"3\" data-media=\"1291\">Cor pulmonale</a></td></tr><tr><td><span ><small>Zero To Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2286\" data-mediaid=\"2286\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2286\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">8</span><button type=\"button\" style=\"\" id=\"media_dislike_2286\" data-mediaid=\"2286\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2286\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/UQGRcg35Dmk\" data-description=\"Cor pulmonale\" data-upvotes=\"7\" data-downvotes=\"3\" data-media=\"897\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/UQGRcg35Dmk/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/UQGRcg35Dmk\" data-description=\"Cor pulmonale\" data-upvotes=\"7\" data-downvotes=\"3\" data-media=\"897\">Cor pulmonale</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1562\" data-mediaid=\"1562\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1562\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">7</span><button type=\"button\" style=\"\" id=\"media_dislike_1562\" data-mediaid=\"1562\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1562\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/XBg6hxGgyS4\" data-description=\"Understanding COPD\" data-upvotes=\"2\" data-downvotes=\"4\" data-media=\"1468\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/XBg6hxGgyS4/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/XBg6hxGgyS4\" data-description=\"Understanding COPD\" data-upvotes=\"2\" data-downvotes=\"4\" data-media=\"1468\">Understanding COPD</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2588\" data-mediaid=\"2588\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2588\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_2588\" data-mediaid=\"2588\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2588\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr></table>",
        "comment_count": 4,
        "concepts_for_notes": {
            "889": {
                "concept_text": "COPD - still breathless despite using SABA/SAMA and <b>no</b> asthma/steroid responsive features --> add a LABA + LAMA",
                "concept_percentile": "70"
            },
            "890": {
                "concept_text": "COPD - still breathless despite using SABA/SAMA and <b>asthma/steroid responsive features</b> --> add a LABA + ICS",
                "concept_percentile": "50"
            },
            "1499": {
                "concept_text": "A SABA or SAMA is the first-line pharmacological treatment of COPD",
                "concept_percentile": "94"
            },
            "7505": {
                "concept_text": "COPD - still breathless despite using SABA/SAMA and a LABA + ICS --> add a LAMA",
                "concept_percentile": "60"
            },
            "9525": {
                "concept_text": "Asthmatic features/features suggesting steroid responsiveness in COPD: \r\n   - previous diagnosis of asthma or atopy\r\n   - a higher blood eosinophil count\r\n   - substantial variation in FEV1 over time (at least 400 ml)\r\n   - substantial diurnal variation in peak expiratory flow (at least 20%)",
                "concept_percentile": "79"
            },
            "9761": {
                "concept_text": "Azithromycin prophylaxis is recommended in COPD patients who meet certain criteria and who continue to have exacerbations",
                "concept_percentile": "87"
            },
            "12253": {
                "concept_text": "COPD standby medication: NICE recommend offering a short course of oral corticosteroids and oral antibiotics to keep at home",
                "concept_percentile": "98"
            }
        },
        "optimisation_reason": ""
    }
]